Annual Meeting Results
Page 1 of 2
Market Release
2 August 2019
2019 Annual Meeting Results
At AFT Pharmaceuticals Limited’s (NZX: AFT / ASX: AFP) shareholder meeting held in Auckland, New
Zealand today, shareholders were asked to vote on four ordinary resolutions and one special resolution,
which were all supported by the Board. All voting was conducted by a poll.
The ordinary resolutions passed by shareholders were:
1. That the directors are authorised to fix the fees and expenses of Deloitte as auditor for the 2020
financial year.
2. That Dr Hartley Atkinson be re-elected as a director of AFT Pharmaceuticals Limited.
3. That Mr Jon Lamb be re-elected as a director of AFT Pharmaceuticals Limited.
4. That Dr John Douglas Wilson be re-elected as a director of AFT Pharmaceuticals Limited.
The special resolution passed by shareholders was:
5. That the existing constitution of the Company is revoked, and the constitution tabled at the
meeting, and referred to in the explanatory notes, is adopted as the constitution of the
Company.
Detail of the total number of votes cast in person or by a proxy holder are:
Resolutions For Against Abstain
1. That the directors are authorised to fix the
fees and expenses of Deloitte as auditor for
the 2020 financial year.
91,099,482
100.00%
0
0.00%
0
2. That Dr Hartley Atkinson be re-elected as a
director of AFT Pharmaceuticals Limited
91,099,197
100.00%
0
0.00%
285
3. That Mr Jon Lamb be re-elected as a director
of AFT Pharmaceuticals Limited.
90,885,868
100.00%
0
0.00%
213,614
4. That Dr John Douglas Wilson be re-elected as
a director of AFT Pharmaceuticals Limited.
91,093,840
100.00%
0
0.00%
5,642
5. That the existing constitution of the
Company is revoked, and the constitution
tabled at the meeting, and referred to in the
explanatory notes, is adopted as the
constitution of the Company.
91,091,235
100.00%
4,524
0.00%
3,723
AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland, 0622, New Zealand
Incorporated in New Zealand ARBN: 609 017 969
Page 2 of 2
Authority for this announcement
Name of person authorised to make this
announcement
Malcolm Tubby, Chief Financial Officer
Contact person for this announcement Malcolm Tubby
Contact phone number +64 9 488 0232
Contact email address Investor.relations@aftpharm.com
Date of release 02/08/2019
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- APL — Asset Plus: Results of Annual Meeting2019-07-30
“NZX RELEASE 30 July 2019 Results of Annual Meeting Asset Plus Limited is pleased to confirm the results of its annual meeting this afternoon. At today’s annual meeting held in Auckland, shareholders were asked to vote on four resolutions, which were all supported by the Bo…”
- AFI — Australian Foundation Investment Company Limited: Results of 2019 Annual General Meeting2019-10-08
“8 October 2019 The Manager ASX Market Announcements Australian Securities Exchange Exchange Centre Level 4 20 Bridge Street Sydney NSW 2000 Electronic Lodgement Australian Foundation Investment Company Limited Results of 2019 Annual General Meeting…”
- SDL — Solution Dynamics Limited: Annual Meeting 2019 – Results2019-10-22
“Physical Address 18-24 Canaveral Drive, Rosedale Postal Address PO Box 301248, Albany Contact Phone: +64 9 970 7700 www.solutiondynamics.com 23 October 2019 Results of Annual Meeting At Solution Dynamics annual shareholder meeting, held in Auckland today, shareho…”